News Focus
News Focus
icon url

oc631

08/23/10 1:10 PM

#102181 RE: ghmm #102156

Good find ghmm. Looks like Roche hasn't given up on ITMN-191.
icon url

DewDiligence

08/23/10 1:28 PM

#102183 RE: ghmm #102156

The new ITMN-191 trial you cited is bearish for the ritonavir-boosted ITMN-191 program, IMO. Rather than progressing to a phase-2b study that measures SVR, Roche is evidently running another small PK/safety study.